Evidence map›Paper›PMID 25687759›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantation.

Sherri Wood, Jiane Feng, Jooho Chung, Vedran Radojcic, Ashley R Sandy-Sloat, Ann Friedman, Amy Shelton, Minhong Yan, Christian W Siebel, D Keith Bishop and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. GCNT1-MediatedJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Solid organ transplantation in the 21Annals of translational medicine · 2018
    Review
  11. Article
  12. Article
  13. Notch Signaling and Immune Regulation in Alloimmunity.Current transplantation reports · 2016
    Article
  14. Review
  15. Targeting the Notch Pathway to Prevent Rejection.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2016
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Sherri WoodDepartment of Surgery, University of Michigan, Ann Arbor, MI 48109;
Jiane FengDepartment of Surgery, University of Michigan, Ann Arbor, MI 48109;
Jooho ChungLife Sciences Institute, University of Michigan, Ann Arbor, MI 48109; Graduate Program in Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI; Medical Scientist Training Program, University of Michigan, Ann Arbor, MI;
Vedran RadojcicLife Sciences Institute, University of Michigan, Ann Arbor, MI 48109; Division of Hematology-Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI;
Ashley R Sandy-SloatLife Sciences Institute, University of Michigan, Ann Arbor, MI 48109; Graduate Program in Immunology, University of Michigan, Ann Arbor, MI;
Ann FriedmanLife Sciences Institute, University of Michigan, Ann Arbor, MI 48109;
Amy SheltonDepartment of Discovery Oncology, Genentech Inc., South San Francisco, CA 94080;
Minhong YanDepartment of Molecular Oncology, Genentech Inc., South San Francisco, CA 94080; and.
Christian W SiebelDepartment of Discovery Oncology, Genentech Inc., South San Francisco, CA 94080;
D Keith BishopDepartment of Surgery, University of Michigan, Ann Arbor, MI 48109; kbishop@umich.edu imaillar@umich.edu.
Ivan MaillardLife Sciences Institute, University of Michigan, Ann Arbor, MI 48109; Division of Hematology-Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI; Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI 48109 kbishop@umich.edu imaillar@umich.edu.
University of Michigan–Ann Arbor · USMichigan Medicine · USSunesis (United States) · USMolecular Oncology (United States) · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
RESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8M
ONCOLOGY RESEARCH TRAINING GRANTT32CA009357 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Qing Li · 1987 to 2026
$8.6M
Notch Signaling in AlloimmunityR01AI091627 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI PEAR, WARREN S · 2011 to 2025
$6.0M
Therapeutic Targets for Chronic Allograft RejectionR01HL070613 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BISHOP, D. KEITH · 2002 to 2014
$4.4M
NCI NIH HHS P30 CA046592NCI NIH HHS T32 CA009357NHLBI NIH HHS HL070613NHLBI NIH HHS R01 HL070613NIAID NIH HHS AI007413NIAID NIH HHS AI091627NIAID NIH HHS R01 AI091627NIAID NIH HHS T32 AI007413NIGMS NIH HHS GM007315NIGMS NIH HHS GM07863NIGMS NIH HHS T32 GM007315NIGMS NIH HHS T32 GM007863
6 · The paper itself

Abstract

Rejection remains a major clinical challenge limiting allograft survival after solid organ transplantation. Both cellular and humoral immunity contribute to this complication, with increased recognition of Ab-mediated damage during acute and chronic rejection. Using a mouse model of MHC-mismatched heart transplantation, we report markedly protective effects of Notch inhibition, dampening both T cell and Ab-driven rejection. T cell-specific pan-Notch blockade prolonged heart allograft survival and decreased IFN-γ and IL-4 production by alloreactive T cells, especially when combined with depletion of recipient CD8(+) T cells. These effects were associated with decreased infiltration by conventional T cells and an increased proportion of regulatory T cells in the graft. Transient administration of neutralizing Abs specific for delta-like (Dll)1/4 Notch ligands in the peritransplant period led to prolonged acceptance of allogeneic hearts, with superior outcome over Notch inhibition only in T cells. Systemic Dll1/4 inhibition decreased T cell cytokines and graft infiltration, germinal center B cell and plasmablast numbers, as well as production of donor-specific alloantibodies and complement deposition in the transplanted hearts. Dll1 or Dll4 inhibition alone provided partial protection. Thus, pathogenic signals delivered by Dll1/4 Notch ligands early after transplantation promote organ rejection through several complementary mechanisms. Transient interruption of these signals represents an attractive new therapeutic strategy to enhance long-term allograft survival.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAntibodies, NeutralizingCalcium-Binding ProteinsCD8-Positive T-LymphocytesFlow CytometryGraft RejectionGraft SurvivalHeart TransplantationImmunityImmunity, CellularImmunity, HumoralIntercellular Signaling Peptides and ProteinsInterferon-gammaInterleukin-4Intracellular Signaling Peptides and ProteinsAdaptor Proteins, Signal TransducingAntibodies, NeutralizingCalcium-Binding ProteinsDlk1 protein, mouseDLL4 protein, mouseIntercellular Signaling Peptides and ProteinsInterferon-gammaInterleukin-4Intracellular Signaling Peptides and ProteinsMembrane ProteinsReceptors, Notch

Identifiers

PMID25687759
PMCPMC4355388
OpenAlexW2154169380

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.